Publisher: Global Market Insights
Category: Gynecological Devices
Category: Gynecological Devices
Gynecological Devices market research reports by Global Market Insights
(2 reports matching your criteria)
-
Uterine Fibroid Treatment Drugs Market - By Drug Class (Progestin-releasing Intrauterine Device, Contraceptive, Gonadotropin-releasing Hormone Antagonist), Type (Submucosal, Intramural), Distribution Channel (Retail, Hospital), Global Forecast, 2023-2032
Uterine Fibroid Treatment Drugs Market - By Drug Class (Progestin-releasing Intrauterine Device, Contraceptive, Gonadotropin-releasing Hormone Antagonist), Type (Submucosal, Intramural), Distribution Channel (Retail, Hospital), Global Forecast, 2023-2032 Uterine Fibroid Treatment Drugs Market size i ... Read More
-
U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook (East North Central (Illinois, Indiana, Michigan, Ohio, Wisconsin), West South Central (Arkansas, Louisiana, Oklahoma, Texas), South Atlantic (Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington, D.C.), North East (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania), East South Central (Alabama, Kentucky, Mississippi, Tennessee), West North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota), Pacific Central (Alaska, California, Hawaii, Oregon, Washington), Mountain States (Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming)), Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
U.S. Intrauterine Devices Market Size By Product (Copper IUD, Hormonal IUD), By Age Group (15-19, 20-24, 25-29, 30-34, 35-39, 40-44, 45+), Industry Analysis Report, Zonal Outlook (East North Central (Illinois, Indiana, Michigan, Ohio, Wisconsin), West South Central (Arkansas, Louisiana, Oklahoma, Te ... Read More